LRRK2 and Parkinson disease: These results suggest that LRRK2 might be involved in the toxic gain of functions of αS. In this regard, it is worth noting that LRRK2-knockout mice showed PD-like pathology, such as αS aggregation and impairment of autophagy-lysosome pathway in their kidneys [42].